These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9218880)

  • 1. Measuring central action of acute antimigraine drugs in humans.
    Schoenen J
    Cephalalgia; 1997 Jun; 17 Suppl 17():12-5; discussion 15-6. PubMed ID: 9218880
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a central action of acute antimigraine drugs essential?
    Goadsby PJ
    Cephalalgia; 1997 Jun; 17 Suppl 17():10-1. PubMed ID: 9218879
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differentiated therapy of migraine attack].
    Skoromets AA; Amelin AV; Korenko LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):39. PubMed ID: 10629928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring event-related potentials.
    Dixon R
    Cephalalgia; 1999 Jul; 19 Suppl 24():29-30; discussion 30-1. PubMed ID: 10526680
    [No Abstract]   [Full Text] [Related]  

  • 5. Zolmitriptan receives migraine indication.
    Am J Health Syst Pharm; 1998 Jan; 55(2):110, 113. PubMed ID: 9465973
    [No Abstract]   [Full Text] [Related]  

  • 6. Zolmitriptan. Introduction.
    Mathew N
    Cephalalgia; 1997 Oct; 17 Suppl 18():1-3. PubMed ID: 9399011
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical applications of zolmitriptan (Zomig, 311C90).
    Lipton RB; Stewart WF
    Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Zolmitriptan].
    Le Jeunne C
    Presse Med; 1999 Sep; 28(28):1525-6. PubMed ID: 10526561
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical effectiveness of 311C90 in the acute treatment of migraine.
    Ferrari MD
    Eur Neurol; 1996; 36 Suppl 2():4-7. PubMed ID: 8791025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attacking migraine headache from beginning to end.
    Moskowitz MA; Cutrer FM
    Neurology; 1997 Nov; 49(5):1193-5. PubMed ID: 9371890
    [No Abstract]   [Full Text] [Related]  

  • 11. Extending therapeutic options? Prospects for the future.
    Edmeads JG
    Eur Neurol; 1996; 36 Suppl 2():32-3. PubMed ID: 8791031
    [No Abstract]   [Full Text] [Related]  

  • 12. A triptan too far?
    Goadsby PJ
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):143-7. PubMed ID: 9489518
    [No Abstract]   [Full Text] [Related]  

  • 13. [Zolmitriptan].
    Monseu G; Sternon J
    Rev Med Brux; 1998 Dec; 19(6):495-9. PubMed ID: 9916496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the options for effective migraine management.
    Goadsby PJ; Olesen J
    Neurology; 1997 Mar; 48(3 Suppl 3):S1-3. PubMed ID: 9071262
    [No Abstract]   [Full Text] [Related]  

  • 15. Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.
    Diener HC; Dowson AJ; Ferrari M; Nappi G; Tfelt-Hansen P
    Cephalalgia; 1999 Oct; 19(8):699-700. PubMed ID: 10570722
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging preclinical and clinical profile of 311C90: a poster review and discussion.
    Ferrari MD
    Eur Neurol; 1996; 36 Suppl 2():19-23. PubMed ID: 8791028
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig).
    Proietti-Cecchini A; Afra J; Schoenen J
    Cephalalgia; 1997 Dec; 17(8):849-54; discussion 799. PubMed ID: 9453273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of 5HT in migraine.
    Buzzi MG
    Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654
    [No Abstract]   [Full Text] [Related]  

  • 19. 311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists.
    Ferrari MD
    Neurology; 1997 Mar; 48(3 Suppl 3):S21-4. PubMed ID: 9071266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V; Kazarawa Z; Fritsche G; Diener HC
    Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.